Last reviewed · How we verify

NCT05805748

Serious Game Therapy in Neglect Patients

Completed NA Last updated 10 April 2023
What this trial tests

NA trial testing serious game rehabilitation in Stroke in 12 participants. Completed in 1 July 2022.

Timeline
6 September 2017
Primary endpoint
5 January 2021
1 July 2022

Quick facts

Lead sponsorHopitaux de Saint-Maurice
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment12
Start date6 September 2017
Primary completion5 January 2021
Estimated completion1 July 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hopitaux de Saint-Maurice

Who can join

Adults 18 to 80, any sex, with Stroke or Unilateral Spatial Neglect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The growing field of new technologies offers new perspectives for neurorehabilitation. Serious games are a promising solution in the rehabilitation of cognitive impairments, and they may be useful in the rehabilitation of unilateral spatial neglect. Investigators developed a rehabilitation program for visual exploration training with a serious game and investigated its efficiency. Twelve patients with unilateral spatial neglect after a right hemispheric stroke were recruited. Six patients assigned to a group received both serious game training and conventional rehabilitation, and after only conventional rehabilitation; and six patients assigned to another group received first conventional rehabilitation and then serious game training and conventional rehabilitation. The investigators compared the two groups after rehabilitation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Hopitaux de Saint-Maurice trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05805748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing